Warning: The NCBI web site requires JavaScript to function. more...
Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study.
Blackman MR, Muniyappa R, Wilson M, Moquin BE, Baldwin HL, Wong KA, Snyder C, Magalnick M, Alli S, Reynolds J, Steinberg SM, Goldbach-Mansky R.
Arthritis Res Ther. 2007;9(4):R73.
Related citations
Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.
Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cédoz JP, Wendling D.
Rheumatology (Oxford). 2005 Jan;44(1):120-5. Epub 2004 Oct 5.
Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
Christiansen JJ, Gravholt CH, Fisker S, Svenstrup B, Bennett P, Veldhuis J, Andersen M, Christiansen JS, Jørgensen JO.
Clin Endocrinol (Oxf). 2004 Apr;60(4):461-9.
Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability, and low bioavailable insulin-like growth factor.
Engvall IL, Elkan AC, Tengstrand B, Cederholm T, Brismar K, Hafstrom I.
Scand J Rheumatol. 2008 Sep-Oct;37(5):321-8.
Serum insulin-like growth factor-axis and matrix metalloproteinases in patients with rheumatic arthritis or rheumatic heart disease.
Lee SD, Chen LM, Kuo WW, Shu WT, Kuo WH, Huang EJ, Tsai CC, Li PC, Liu JY, Chen TH, Huang CY.
Clin Chim Acta. 2006 May;367(1-2):62-8. Epub 2006 Jan 9.
Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids.
Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, Seriolo B, Giusti M, Accardo S.
J Rheumatol. 1999 Feb;26(2):282-8.
Adrenal plasma steroid relations in glucocorticoid-naïve premenopausal rheumatoid arthritis patients during insulin-induced hypoglycemia test compared to matched normal control females.
Imrich R, Vigas M, Rovensky J, Aldag JC, Masi AT.
Endocr Regul. 2009 Apr;43(2):65-73.
Dehydroepiandrosterone secretion in healthy older men and women: effects of testosterone and growth hormone administration in older men.
Muniyappa R, Wong KA, Baldwin HL, Sorkin JD, Johnson ML, Bhasin S, Harman SM, Blackman MR.
J Clin Endocrinol Metab. 2006 Nov;91(11):4445-52. Epub 2006 Aug 22.
Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M.
Arthritis Rheum. 2002 Mar;46(3):654-62.
Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycaemia in premenopausal women with rheumatoid arthritis.
Imrich R, Rovensky J, Malis F, Zlnay M, Killinger Z, Kvetnansky R, Huckova M, Vigas M, Macho L, Koska J.
Ann Rheum Dis. 2005 Feb;64(2):202-6.
Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
Rasmussen MH, Wildschiødtz G, Juul A, Hilsted J.
Obesity (Silver Spring). 2008 Jul;16(7):1516-21. Epub 2008 May 8.
Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia.
Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, Copello F, Rodriguez G, Polleri A.
J Endocrinol Invest. 2001 Mar;24(3):139-46.
Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion.
Rall LC, Walsmith JM, Snydman L, Reichlin S, Veldhuis JD, Kehayias JJ, Abad LW, Lundgren NT, Roubenoff R.
Arthritis Rheum. 2002 Oct;46(10):2574-7.
Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis.
Boss B, Neeck G.
Z Rheumatol. 2000;59 Suppl 2:II/62-4.
Effects of mirthful laughter on growth hormone, IGF-1 and substance P in patients with rheumatoid arthritis.
Ishigami S, Nakajima A, Tanno M, Matsuzaki T, Suzuki H, Yoshino S.
Clin Exp Rheumatol. 2005 Sep-Oct;23(5):651-7.
Adrenocortical response to low-dose ACTH test in female patients with rheumatoid arthritis.
Radikova Z, Rovensky J, Vlcek M, Penesova A, Kerlik J, Vigas M, Imrich R.
Ann N Y Acad Sci. 2008 Dec;1148:562-6.
Prolactin and growth hormone responses to hypoglycemia in patients with rheumatoid arthritis and ankylosing spondylitis.
Rovensky J, Imrich R, Malis F, Zlnay M, Macho L, Koska J, Vigas M.
J Rheumatol. 2004 Dec;31(12):2418-21.
The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.
Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R.
Clin Endocrinol (Oxf). 2002 May;56(5):655-69.
Fasting as a metabolic stress paradigm selectively amplifies cortisol secretory burst mass and delays the time of maximal nyctohemeral cortisol concentrations in healthy men.
Bergendahl M, Vance ML, Iranmanesh A, Thorner MO, Veldhuis JD.
J Clin Endocrinol Metab. 1996 Feb;81(2):692-9.
Growth hormone and prolactin are secreted more irregularly in patients with Cushing's disease.
Veldman RG, Frölich M, Pincus SM, Veldhuis JD, Roelfsema F.
Clin Endocrinol (Oxf). 2000 May;52(5):625-32.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on